Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant.

Although the survival rate analyzed by log-rank test did not reach statistical significance, the weight changes showed that the mice given the GT or EGCG-adjuvanted GD were significantly less susceptible to the challenge.

also in 111,027 other papers